Whalesbook
Asal mein, 4th May ko market mein price action aur technical indicators ka hi sabse zyada zor dikha. Bahut saare stocks mein move aaya bina kisi bade fundamental reason ke. Matlab, chart patterns hi decide kar rahe the ki investors kya karenge.
Is mein sabse pehle naam aata hai Dar Credit ka, jo 7.84% bhadkar ₹41.00 par pahunch gaya. Yeh stock apne 30-day aur 50-day moving averages ke upar nikla, jo short-term momentum ka sign hai. Phir aaya Dr Lal PathLabs, jo 6.99% badhkar ₹1,468.60 par pahuncha. Yeh diagnostic major toh apne 30-day aur 50-day averages ke upar comfortably chal raha hai aur 150-day ( 1,462.43 ) aur 200-day ( 1,495.34 ) averages ke kareeb ja raha hai, jo recovery dikha raha hai. JHS Svendgaard Laboratories bhi 4.66% badhkar ₹20.90 par tha, yeh bhi short-term strength dikha raha hai.
Us taraf, Nidan Laboratories aur Healthcare mein selling pressure raha, yeh 7.59% girkar ₹13.75 par aa gaya, jo sabhi key moving averages ke neeche trade ho raha hai, matlab weakness dikhata hai. Sun TV Network bhi 4.40% girkar ₹577.50 par aa gaya, yeh bhi 30-day aur 50-day averages ke neeche hai, lekin 150-day aur 200-day averages shayad thoda support de dein. The Byke Hospitality bhi 2.42% girkar ₹35.07 par tha, yeh bhi pressure mein dikh raha tha.
Market ka ek section toh technical breakouts se tezi se bhaga. California Software, Omax Autos, Axiscades Technologies, Sterlite Technologies, aur DCM Shriram Fin toh seedha upper circuit par pahunch gaye. Yeh dikhata hai ki speculative buying kaafi strong thi. Aur toh aur, Bajaj Auto, Adani Ports, Siemens, aur Bandhan Bank jaise kai bade stocks ne toh apne 52-week highs bhi tod diye. Yeh broad demand ko represent karta hai, bina kisi bade news ke.
Ab thoda deep dive karte hain. Dr Lal PathLabs ka P/E ratio lagbhag 45x hai, jo healthcare diagnostics sector mein hai. Iske competitors, Metropolis Healthcare aur Thyrocare, ka P/E roughly 50x aur 35x hai. To Dr Lal PathLabs apne segment mein moderate valuation par hai. Analysts ka Dr Lal PathLabs par view mixed hai, target price ₹1500-1600 ke aas-paas hai, jo short-term mein zyada upside nahi dikhata.
Wahi Sun TV Network, jo media sector mein hai, ka P/E lagbhag 20x hai, jo Zee Entertainment (approx. 30x P/E) aur Network18 (approx. 25x P/E) se kam hai. Media sector mein digital disruption aur ad revenue ki volatility challenges hain, lekin digital growth ek potential offset hai. Analysts ka Sun TV par view 'Buy' ya 'Hold' ki taraf hai, target price ₹600-650 ke aas-paas hai, jo upside dikha sakta hai agar stock apne long-term averages ko pakad le.
Magar, risk bhi hai! Dr Lal PathLabs jaise momentum stocks agar 45x jaise high valuation par hain, toh revenue growth ya margin mein slowdown aaya toh yeh stocks gire bhi sakte hain. Competitors ka P/E kam hai, jo batata hai ki Dr Lal PathLabs ka valuation stretched ho sakta hai agar earnings na badhein. Sun TV Network ke liye, 30-day aur 50-day moving averages ke neeche trade karna weakness dikhata hai, jo sideways ya downward trend ko lamba kar sakta hai, khaas kar agar ad revenue pressure mein rahi aur digital media mein competition badha. Media landscape mein traditional broadcasting par reliance ek structural risk hai.
Brokerages ka Dr Lal PathLabs par outlook cautious hai, targets current levels ke aas-paas hain, matlab sector ka positive outlook shayad already priced in hai. Sun TV Network mein upside potential hai agar short-term hurdles paar kiye aur digital initiatives ko leverage kiya. Market mein technical breakouts ka chalna yahi batata hai ki short-term trading jaise chal rahi hai, waise hi chal sakti hai, jab tak koi bada fundamental catalyst na aaye.